Bellevue Life Sciences Ac...

NASDAQ: BLACU · Real-Time Price · USD
3.36
-3.74 (-52.68%)
At close: Feb 14, 2025, 3:54 PM

Bellevue Life Sciences Acquisition Revenue

Bellevue Life Sciences Acquisition reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending September 30, 2024, Bellevue Life Sciences Acquisition generated $0 in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
6.98M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.